NOX4 regulates TGFβ‐induced proliferation and self‐renewal in glioblastoma stem cells

Abstract

Glioblastoma (GBM) is the most aggressive and common glioma subtype, with a median survival of 15 months after diagnosis. Current treatments have limited therapeutic efficacy; thus, more effective approaches are needed. The glioblastoma tumoural mass is characterised by a small cellular subpopulation – glioblastoma stem cells (GSCs) – that has been held responsible for glioblastoma initiation, cell invasion, proliferation, relapse and resistance to chemo‐ and radiotherapy. Targeted therapies against GSCs are crucial, as is understanding the molecular mechanisms that govern the GSCs. Transforming growth factor β (TGFβ) signalling and reactive oxygen species (ROS) production are known to govern and regulate cancer stem cell biology. Among the differentially expressed genes regulated by TGFβ in a transcriptomic analysis of two different patient‐derived GSCs, we found NADPH oxidase 4 (NOX4) as one of the top upregulated genes. Interestingly, when patient tissues were analysed, NOX4 expression was found to be higher in GSCs versus differentiated cells. A functional analysis of the role of NOX4 downstream of TGFβ in several patient‐derived GSCs showed that TGFβ does indeed induce NOX4 expression and increases ROS production in a NOX4‐dependent manner. NOX4 downstream of TGFβ regulates GSC proliferation, and NOX4 expression is necessary for TGFβ‐induced expression of stem cell markers and of the transcription factor nuclear factor erythroid 2‐related factor 2 (NRF2), which in turn controls the cell’s antioxidant and metabolic responses. Interestingly, overexpression of NOX4 recapitulates the effects induced by TGFβ in GSCs: enhanced proliferation, stemness and NRF2 expression. In conclusion, this work functionally establishes NOX4 as a key mediator of GSC biology.

Human Umbilical Cord Mesenchymal Stem Cells Improve Premature Ovarian Failure through Cell Apoptosis of miR-100-5p/NOX4/NLRP3

“…The main biological function of NOX family proteins is to produce ROS, which can maintain the normal physiological activities of cells [ 30 ]. Oxidative stress caused by increased ROS in the body is related to a variety of diseases.…”

Glutamine deprivation alters TGF-β signaling in hepatocellular carcinoma

“…In addition to the respiratory chain contribution to ROS synthesis, the elevation of ROS levels can be contributed to the NADPH-oxidase family (Nox) of proteins. Cancer stem cells are known to have high basal levels of ROS, and among other Nox members, NOX4, which is constitutively active in cells, is known to regulate the expression of cancer stem cell genes in glioblastoma (Garcia-Gomez et al , 2022) and promote oncogenesis in pancreatic cancer (Ju et al , 2017). On the other hand, NOX4 has been reported to act as a tumour suppressor or oncogene depending on the tumour type.…”

A mini‐review on anticancer‐related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma

“…Ford and colleagues in 2020 found that CAFs-rich TC1 and MC38 tumour models hampered cancer immunotherapy efficacy, whereas NOX4 inhibition not only reversed it but also suppressed TGFβ-induced myofibroblast differentiation and normalised CAFs to quiescence [51]. Indeed, higher NOX4 expression has been observed in gallbladder CAFs [52] and primary GSCs [54], as well as is associated with poor patient survival [52,54,55]. Besides, NOX4 overexpression in normal breast epithelial cells leads to senescence, apoptosis resistance and tumorigenic transformation [56].…”